KROS icon

Keros Therapeutics
KROS

Overview Fund Activity

112 hedge funds and large institutions have $617M invested in Keros Therapeutics in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 15 closing their positions.

Holders
112
Holders Change
+9
Holders Change %
+8.74%
% of All Funds
1.94%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
24
Increased
39
Reduced
25
Closed
15
Calls
$5.77M
Puts
$3K
Net Calls
+$5.76M
Net Calls Change
+$3.93M

Top Buyers

1
WP
1
Woodline Partners
California
$12.9M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$145M
3
CIBC Asset Management
3
CIBC Asset Management
Ontario, Canada
$5.51M
4
SCM
4
Soleus Capital Management
Connecticut
$5.49M
5
SFM
5
Sphera Funds Management
Israel
$7.78M

Top Sellers

1
DTC
1
Deep Track Capital
Connecticut
$9.35M
2
OCA
2
Octagon Capital Advisors
New York
$0
3
Allianz Asset Management
3
Allianz Asset Management
Germany
$685K
4
NCM
4
Nantahala Capital Management
Connecticut
$31.8M
5
Morgan Stanley
5
Morgan Stanley
New York
$2.31M
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
126
Concourse Financial Group Securities
Alabama
– – – –
PA
127
Parallel Advisors
California
$0 4 +4 New
S
128
SignatureFD
Georgia
$0 10 +10 New
2 3 4 5
6